iPSC-Derived Microglia With Media

$1,650.00

SKU ASE-9601-1 Category

iPSC-Derived Microglia

With Media

Microglia are the primary immune cells in the central nervous system (CNS)  and play a crucial role in maintaining neuronal homeostasis and synaptic plasticity for normal brain development, neuronal function, and inflammatory responses. Microglia have also been implicated in the pathogenesis of several neurological disorders such as Alzheimer’s disease and Parkinson’s disease. The differentiation of iPSCs to microglia provide a steady source of primary microglia-like cells without the sourcing issues associated with primary microglia. These cells are an excellent physiologically relevant research model for studying immune response mechanisms in the brain, for understanding neuronal function, and for disease modeling.

Our efficient cytokine-based method for differentiating high-quality microglia cells from human iPSCs (iMGLs) recapitulates the phenotype and functional parameters of primary and in vivo microglial cells. Our proprietary erythromyeloid induction protocol mimics the in vivo activation pathway for developing microglia in the brain from hematopoietic stem cells.

Donor information and characterization data

Table Header Table Header
Age
Neonate
Gender
Male
Ethnicity
African American
Tissue source
Dermal fibroblasts
Reprogramming method
Episomal
Culture conditions
Feeder-free

The iMGLs were derived through directed differentiation from an integration-free, control human iPSC line (ASE-9211) reprogrammed from fibroblasts of an African American male donor. These high purity (>90%) cells express microglial-specific markers TMEM119, P2Ry12+, IBA1, CX3CR1+, and TREM2+. The cells are provided as fully differentiated, cryopreserved cells that you can readily recover and culture for your experiments. The iMGLs are functionally viable for 7 days after recovery.